Illumina

Illumina & NVIDIA Partner to Advance AI-Driven Multiomic Data Analysis for Precision Health January 16, 2025 Illumina partners with NVIDIA to enhance multiomic data analysis, leveraging AI for advancements in genomics, drug discovery, and precision health.

Illumina Expands Global Presence with New Capability Center in Bengaluru September 2, 2024 Bengaluru joins Singapore, Cambridge, Eindhoven, Shanghai, Madison, Hayward, and San Diego as an Illumina Global Capability Center.

Illumina Acquires Fluent BioSciences to Expand Single-Cell Analysis Capabilities July 12, 2024 Illumina, a global leader in DNA sequencing and array-based technologies, has acquired Fluent BioSciences, a developer of a novel single-cell technology.

Illumina Unveils DRAGEN v4.3 for Next-Generation Sequencing June 14, 2024 A key feature of DRAGEN v4.3 is the ability for researchers to create custom multigenome references directly on the Illumina cloud.

Concentric by Ginkgo & Illumina Partner to Strengthen Biosecurity Capabilities January 16, 2024 As per the agreement, partners aim to showcase Illumina product integration with Concentric's bioradar. This collaboration aims to empower countries by increasing the scale of global pathogen surveillance, and improve early warning for emerging threats.

Illumina Launches Global Health Access Initiative to Accelerate Pathogen Sequencing in LMIC Countries November 16, 2023 Reportedly, the pricing for its sequencing instruments and consumables can vary by country or region. However, the biotech company, in accordance with guidance from customers, funders, and market facilitators, will provide discounted prices for a range of sequencing applications.

Illumina Expands Presence in India with New Solutions Centre to Drive Genomics Advancements August 21, 2023 Illumina Inc., a U.S.-based company specialising in DNA sequencing and array-based technologies, has announced the opening of a new office along with an advanced Illumina Solutions Centre in Bengaluru, India.